Stay updated on Clinical Trial of IL-2 + Nivolumab in RCC

Sign up to get notified when there's something new on the Clinical Trial of IL-2 + Nivolumab in RCC page.
Latest website image capture
Clouds background image

Latest updates to the Clinical Trial of IL-2 + Nivolumab in RCC page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The clinical-trial record for a Phase Ib/II study combining high-dose interleukin-2 and nivolumab for metastatic clear cell renal cell cancer is displayed, including study design, eligibility, outcomes, and locations. The record indicates the study is completed and no longer recruiting.
    Difference
    50%
    Check dated 2026-11-07T16:10:47.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T16:34:46.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    A sitewide banner announces an NIH content transition, noting that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” and linking to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T22:06:19.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The footer’s revision identifier updates from v3.7.1 to v3.7.2 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-17T22:18:20.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The footer now displays site revision v3.7.1 instead of v3.7.0, while the page continues to show a 403 error.
    Difference
    0.2%
    Check dated 2026-10-10T22:14:27.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    The 403 error page elements were removed, including the 403 message and the error HTML snippet. The page now loads as a standard study details page with the usual header and footer.
    Difference
    0.5%
    Check dated 2026-09-26T21:57:26.000Z thumbnail image

Stay in the know with updates to Clinical Trial of IL-2 + Nivolumab in RCC

Enter your email address, and we'll notify you when there's something new on the Clinical Trial of IL-2 + Nivolumab in RCC page.